临床试验样本量估计中两次测量相减法的局限性
该研究讨论仅利用两个时间点数据、通过相减基线测量与随访测量来估计随机临床试验样本量这一做法的局限性,推导数学条件并用阿尔茨海默病神经影像学倡议(ADNI)的MRI海马体积数据及蒙特卡洛模拟(MCS)展示偏差与变异性,MCS显示样本量可被系统性高估或低估达32.27%偏差,作者建议使用两次以上测量及线性混合效应模型等更全面方法。
要点
- 仅用两个时间点测量相减估计样本量可能产生系统性偏差,MCS中偏差达32.27%。
- 该相减法在错误处理测量误差时可导致样本量与试验时长无关。
- 作者推荐使用两次以上测量及线性混合效应模型等更全面方法估计样本量。
核心结论
- 通过相减两次测量来估计样本量应谨慎对待,此类估计可能存在偏差,偏差大小取决于计划中的随机临床试验时长。
- 为估计样本量,作者推荐使用两次以上测量以及线性混合效应模型等更全面的方法。
研究设计与样本
- 研究推导数学方程以证明具有可变时间间隔的成对数据在何种条件下可充分估计样本量。
- 使用阿尔茨海默病神经影像学倡议(ADNI)的基于MRI的海马体积测量和蒙特卡洛模拟(MCS)来说明估计的现有偏差与变异性。
主要发现
- MCS结果支持理论上推导出的相减法可能有效的条件。
- MCS还显示样本量被系统性低估或高估,偏差高达32.27%。
- 若使用不当,该相减法输出的样本量与试验时长无关,部分原因在于测量误差的处理方式。
临床怎么用
- 作者认为通过相减两次测量来估计样本量应谨慎对待。
- 作者建议为估计样本量使用两次以上测量以及线性混合效应模型等更全面的方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In planning randomized clinical trials (RCTs) for diseases such as Alzheimer's disease (AD), researchers frequently rely on the use of existing data obtained from only two time points to estimate sample size via the subtraction of baseline from follow-up measurements in each subject. However, the inadequacy of this method has not been reported. The aim of this study is to discuss the limitation of sample size estimation based on the subtraction of available data from only two time points for RCTs. Mathematical equations are derived to demonstrate the condition under which the obtained data pairs with variable time intervals could be used to adequately estimate sample size. The MRI-based hippocampal volume measurements from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Monte Carlo simulations (MCS) were used to illustrate the existing bias and variability of estimates. MCS results support the theoretically derived condition under which the subtraction approach may work. MCS also show the systematically under- or over-estimated sample sizes by up to 32.27 % bias. Not used properly, such subtraction approach outputs the same sample size regardless of trial durations partly due to the way measurement errors are handled. Estimating sample size by subtracting two measurements should be treated with caution. Such estimates can be biased, the magnitude of which depends on the planned RCT duration. To estimate sample sizes, we recommend using more than two measurements and more comprehensive approaches such as linear mixed effect models.
引用
- Chen K, Guo X, Pan R, et al. Limitations of clinical trial sample size estimate by subtraction of two measurements. Stat Med. 2021. PMID: 34725853. doi:10.1002/sim.9244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。